Horizon TherapeuticsHZNP
13F holders, Q2 2024 (June 30)2holders +1
0new positions
0sold out
$109.72avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Horizon Therapeutics PLC (HZNP) in their 13F filings, up 1 from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Strategic Investment Solutions, Inc. ($4K) and Huntington National Bank ($116).
- Company
- Horizon Therapeutics PLC
- CUSIP
- G46188101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Strategic Investment Solutions, Inc. | 0.00% | — | 35 | $4K |
| Huntington National Bank | 0.00% | No change | 1 | $116 |
"% of holder's portfolio" is HZNP's weight in each manager's 13F, not the share of Horizon Therapeutics PLC the manager owns.